Yesterday, the biomedical project forge of the state of Lower Saxony reviewed the most promising ideas from across the region and selected the winners: At the fourth portfolio conference of the Institute for Biomedical...
Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access. A team headed by Tobias Gulder from the...
Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Centre for Infection Research (HZI) and the Medical Center - University of Freiburg has developed a method...
The Helmholtz Centre for Infection Research (HZI) has a lot to offer its doctoral candidates: Together with renowned partner institutions, the center has developed high-quality doctoral programs that impart in-depth...
Every two years, the MDPI Sustainability Foundation presents the Tu Youyou Award for outstanding achievements in the fields of natural product and medicinal chemistry. This year, Rolf Müller is one of two researchers to...
Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) are working on innovative...
Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment options. A team of...
Organoids are a pioneering tool in biomedical research. These tiny, organ-like cell structures are grown from stem cells and open up completely new possibilities for studying infectious diseases in human tissue. In this...
Scientists at the Helmholtz Centre for Infection Research (HZI) are studying important mechanisms for the development of infectious diseases and how they can be treated or prevented. Some of the research questions can...
